Myelodysplastic Syndrome Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Collection of Tissue Samples for Cancer Research
Recruiting
  • Neoplasms
  • +3 more
    • Iowa City, Iowa
    • +6 more
    2022-01-13
    Jan 13, 2022
    F
    Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant - 2021
    Completed
    • Acute Biphenotypic Leukemia
    • +6 more
    • Aurora, Colorado
    • +2 more
    2022-01-12
    Jan 12, 2022
    I
    National Longitudinal Cohort of Hematological Diseases
    Recruiting
    • Multiple Myeloma
    • +17 more
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      2022-01-11
      Jan 11, 2022
      S
      Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
      Active, not recruiting
      • Acute Myeloid Leukemia
      • +66 more
      • Best Practice
      • +3 more
      • Fullerton, California
        Virginia K Crosson Cancer Center
      2022-01-11
      Jan 11, 2022
      A
      A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndrome
      • ASP7517
      • Duarte, California
      • +15 more
      2022-01-12
      Jan 12, 2022
      H
      Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
      Active, not recruiting
      Has Results
      • Myelodysplastic Syndrome
      • +3 more
      • Tampa, Florida
      • +5 more
      2022-01-03
      Jan 3, 2022
      B
      Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • MultiTAA-specific T cells
      • Houston, Texas
      • +1 more
      2022-01-06
      Jan 6, 2022
      M
      Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant - 2021
      Completed
      • Acute Lymphoblastic Leukemia in Remission
      • +6 more
      • Allogeneic Bone Marrow Transplantation
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      2021-12-15
      Dec 15, 2021
      F
      Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
      Suspended
      • Acute Leukemia
      • +18 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      2021-12-16
      Dec 16, 2021
      F
      Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      2022-01-03
      Jan 3, 2022
      N
      Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (CPX-351) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
      Suspended
      • Acute Myeloid Leukemia
      • +5 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center LAO
      2021-12-29
      Dec 29, 2021
      M
      Venetoclax, Busulfan, Cladribine, and Fludarabine for the Treatment of High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
      Recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      2021-12-28
      Dec 28, 2021
      G
      Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS) - 2015
      Completed
      • Myelodysplastic Syndrome
      • Amiens, France
      • +20 more
      2021-12-24
      Dec 24, 2021
      P
      A Study of PRT1419 Injection in Patients With Relapsed/Refractory Hematologic Malignancies
      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Port Jefferson Station, New York
      • +1 more
      2021-12-23
      Dec 23, 2021
      F
      Cord Blood Transplant With OTS for the Treatment of HIV Positive Hematologic Cancers
      Recruiting
      • Acute Erythroid Leukemia
      • +10 more
      • San Francisco, California
      • +4 more
      2021-12-23
      Dec 23, 2021
      M
      Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome
      Recruiting
      • Chronic Myelomonocytic Leukemia
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      2021-12-21
      Dec 21, 2021
      A
      Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies - 2019
      Terminated
      • Multiple Myeloma
      • +6 more
      • AMG 397
      • +2 more
      • Birmingham, Alabama
      • +20 more
      2021-12-20
      Dec 20, 2021
      L
      Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
      Not yet recruiting
      • Allogeneic Stem Cell Transplant Candidate
      • +4 more
      • Cellular therapy product
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      2021-12-02
      Dec 2, 2021
      F
      Blood Samples to Identify Biomarkers of Busulfan
      Active, not recruiting
      • Leukemia
      • +4 more
        • Seattle, Washington
          University of Washington
        2021-12-14
        Dec 14, 2021
        N
        Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
        Active, not recruiting
        Has Results
        • Acute Myeloid Leukemia
        • +19 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +8 more
        • Lewes, Delaware
        • +16 more
        2021-12-14
        Dec 14, 2021
        A
        A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
        Recruiting
        • Relapsed/Refractory AML
        • +2 more
        • AMG 330
        • Birmingham, Alabama
        • +10 more
        2021-12-09
        Dec 9, 2021
        M
        Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +14 more
        • Aldesleukin
        • +7 more
        • Houston, Texas
          M D Anderson Cancer Center
        2021-12-01
        Dec 1, 2021
        F
        Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
        Active, not recruiting
        • Myelodysplastic Syndrome
        • Strasbourg, Bajo Rin, France
        • +24 more
        2021-11-22
        Nov 22, 2021
        M
        Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
        Recruiting
        • Aplastic Anemia
        • +3 more
        • Anti-Thymocyte Globulin
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        2021-12-01
        Dec 1, 2021
        C
        90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +3 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +8 more
        • Duarte, California
          City of Hope Medical Center
        2021-11-22
        Nov 22, 2021